Biomea Fusion, Inc.
BMEA
$1.34
-$0.09-6.29%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/21/2026
-
MarketBeat
1/19/2026
-
Yahoo! Finance: News
1/16/2026
-
Insider Monkey
1/16/2026
-
SeekingAlpha
1/15/2026
-
MarketBeat
1/15/2026
-
Seeking Alpha: Transcripts
1/15/2026
-
SeekingAlpha
1/15/2026
-
GuruFocus
1/13/2026
-
TipRanks Financial Blog
1/13/2026
-
The Fly
1/13/2026
-
MarketBeat
1/13/2026
-
MarketBeat
1/12/2026
-
The Fly
1/12/2026
-
GuruFocus
1/12/2026
-
Globe Newswire
12/27/2025
-
MarketBeat
12/17/2025
-
GuruFocus
12/17/2025
-
Globe Newswire
12/16/2025
-
MarketBeat
12/15/2025
-
MarketBeat
12/13/2025
-
GuruFocus
12/11/2025
-
Simply Wall St
12/10/2025
-
GuruFocus
12/10/2025
-
TipRanks Financial Blog
12/10/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 980 9099
Address
1599 Industrial Road
San Carlos, CA 94070
San Carlos, CA 94070
Country
Year Founded
Business Description
Sector
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic...
more